- Home
- GROV vs MDAI Comparison
GROV vs MDAI Comparison
Compare GROV & MDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GROV | MDAI |
|---|---|---|
| Founded | 2016 | 2013 |
| Country | United States | United States |
| Employees | 295 | 65 |
| Industry | Package Goods/Cosmetics | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.4M | 60.1M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | GROV | MDAI |
|---|---|---|
| Price | $1.19 | $1.83 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $1.60 | ★ $3.00 |
| AVG Volume (30 Days) | 56.8K | ★ 922.1K |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.81 | $23.50 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.03 | $1.18 |
| 52 Week High | $1.60 | $3.21 |
Technical Indicators
Market Signals| Indicator | GROV | MDAI |
|---|---|---|
| Relative Strength Index (RSI) | 48.52 | 38.74 |
| Support Level | $1.10 | $1.78 |
| Resistance Level | $1.47 | $2.03 |
| Average True Range (ATR) | 0.08 | 0.19 |
| MACD | 0.00 | -0.06 |
| Stochastic Oscillator | 72.10 | 1.29 |
Price Performance
Historical ComparisonAbout GROV Grove Collaborative Holdings Inc.
Grove Collaborative Holdings Inc is a digital-first, sustainability-oriented consumer products innovator specializing in the development and sale of household, personal care, beauty and other consumer products with a human and environmental focus. The Company sells its products through a direct-to-consumer (DTC) platform and the Company's mobile applications, where the Company sells products from Grove-owned brands (Grove Brands) and third-parties.
About MDAI Spectral AI Inc.
Spectral AI Inc is an AI company focused on predictive medical diagnostics. Its DeepView System uses proprietary AI algorithms to distinguish between fully damaged, partially damaged and healthy human tissue characters invisible to the naked eye, at the initial time point of wound presentation. The DeepView System delivers a binary prediction on the wound's capacity to heal or not-heal by a specified time point in the future. The company focuses on the burn indication which is supported by the BARDA PBS contract.